Recruiting
ASMact: Study on Management of Bronchial Asthma
Standardization According to GINA 2025 Recommendations for the Treatment, Management, and Follow-up of Acute Asthma Attacks: Observational, Multicenter Cohort Study.
ClinicalTrials.gov IDNCT07412769
PhaseNot Applicable
Enrollment500
SponsorMeyer Children's Hospital IRCCS
Age6 Years – 17 Years
SexALL
Conditions studied
Asthma Acute, Asthma Childhood, Asthma in Children, Asthma Crisis
About this study
Standardization According to GINA 2025 Recommendations for the Treatment, Management, and Follow-up of Acute Asthma Attacks: Observational, Multicenter Cohort Study.
Primary outcomes
- Change in the number of correctly reported diagnoses before and after intervention (Pre-intervention and through study completion, an average of 9 months)
- Percentage of patients with correct timing, dosage, and method of drug administration before and after intervention (Pre-intervention and through study completion, an average of 9 months)
- Percentage of patients with correct follow-up at discharge (Pre-intervention and through study completion, an average of 9 months)
- Percentage of patients in whom additional drugs are used in refractory cases (Pre-intervention and through study completion, an average of 9 months)
- Percentage of patients with correct therapy at discharge (Pre-intervention and through study completion, an average of 9 months)
Eligibility information
Inclusion Criteria:
* Age between 6 and 17 years
* Presentation to the emergency department with a diagnosis of acute asthma exacerbation
* Evaluation in the emergency department of one of the participating centers during the study periods
Exclusion Criteria:
* Age \< 6 years or \> 17 years
* Diagnosis other than acute asthma exacerbation
* Incomplete or missing clinical data
* Patients transferred from other hospitals already treated for the same episode
* history of allergy to any drugs used in the protocol
Study locations
- Arcispedale S. Anna, Ferrara, FE 44124 Italy
- Meyer Children's Hospital IRCCS, Firenze, Florence, 50134 Italy
Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-10-09.